Orthofix Medical Retained Earnings 2011-2026 | OFIX

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.

Possible uses include

reinvestment in development (R&D, equipment, marketing)
debt repayment
acquisition of other companies
creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings Orthofix Medical

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-368 M	-276 M	-150 M	1.25 M	21 M	59.4 M	57.7 M	87.1 M	70.4 M	64.2 M	62.6 M	65.4 M	89.3 M	149 M	97.3 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
149 M	-368 M	1.96 M

Quarterly Retained Earnings Orthofix Medical

2026-Q1	2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-389 M	-368 M	-366 M	-343 M	-329 M	-276 M	-247 M	-220 M	-186 M	-150 M	-128 M	-99.1 M	-59.7 M	1.25 M	8.31 M	-	16.5 M	21 M	53.8 M	56 M	53.6 M	59.4 M	59.4 M	59.4 M	59.4 M	57.7 M	57.7 M	57.7 M	57.7 M	87.1 M	87.1 M	87.1 M	87.1 M	70.4 M	70.4 M	70.4 M	70.4 M	64.2 M	64.2 M	64.2 M	64.2 M	62.6 M	62.6 M	62.6 M	62.6 M	65.4 M	65.4 M	65.4 M	65.4 M	73.9 M	73.9 M	73.9 M	73.9 M	103 M	115 M	115 M	115 M	72 M	97.3 M	97.3 M	97.3 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
115 M	-389 M	363 K

Retained Earnings of other stocks in the Medical devices industry

Issuer	Retained Earnings	Price	% 24h	Market Cap	Country
Cutera CUTR	-303 M	-	-10.19 %	$ 1.99 M	USA
EDAP TMS S.A. EDAP	-82.6 M	-	-	$ 162 M	France
GenMark Diagnostics, Inc. GNMK	-533 M	-	-	$ 1.77 B	USA
Avinger AVGR	-421 M	-	-20.74 %	$ 369 K	USA
Axonics Modulation Technologies AXNX	-380 M	-	-	$ 3.31 B	USA
Eargo EAR	-514 M	-	-	$ 10.2 M	USA
Allied Healthcare Products AHPI	-15.7 M	-	3.58 %	$ 2.21 M	USA
Obalon Therapeutics, Inc. OBLN	-185 M	-	-5.86 %	$ 30.6 M	USA
ClearPoint Neuro CLPT	-217 M	$ 12.89	-9.99 %	$ 365 M	USA
Apollo Endosurgery APEN	-337 M	-	-	$ 475 M	USA
Alphatec Holdings ATEC	-1.42 B	$ 8.0	1.01 %	$ 1.2 B	USA
Aziyo Biologics AZYO	-176 M	-	1.37 %	$ 20.5 M	USA
BioSig Technologies BSGM	-718 M	-	37.08 %	$ 85.7 M	USA
BIOLASE BIOL	-317 M	-	-13.19 %	$ 166 K	USA
IRIDEX Corporation IRIX	-92.4 M	$ 1.09	-5.22 %	$ 18.5 M	USA
Conformis CFMS	-581 M	-	-	$ 16.4 M	USA
Cardiovascular Systems CSII	-424 M	-	0.15 %	$ 844 M	USA
Helius Medical Technologies HSDT	-213 M	$ 1.27	-9.29 %	$ 28 M	USA
CryoLife, Inc. CRY	20 M	-	-4.14 %	$ 702 M	USA
LivaNova PLC LIVN	-1.15 B	$ 72.36	-1.84 %	$ 3.95 B	Britain
Cytosorbents Corporation CTSO	-312 M	$ 0.46	-5.94 %	$ 28.6 M	USA
LENSAR LNSR	-178 M	$ 5.6	-0.36 %	$ 67 M	USA
Pulmonx Corporation LUNG	-522 M	$ 1.53	-5.56 %	$ 62.2 M	USA
OrthoPediatrics Corp. KIDS	-275 M	$ 18.32	1.22 %	$ 430 M	USA
MiMedx Group MDXG	-42.7 M	$ 3.74	-1.06 %	$ 553 M	USA
Delcath Systems DCTH	-529 M	$ 10.67	-1.11 %	$ 382 M	USA
Soliton, Inc. SOLY	-70.6 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	-56.2 M	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	-119 M	-	0.03 %	$ 1.58 B	Israel
Myomo MYO	-119 M	$ 1.28	-0.78 %	$ 53.6 M	USA
Misonix, Inc. MSON	-39.3 M	-	-	$ 462 M	USA
Neovasc NVCN	-420 M	-	-	$ 111 M	Canada
Dynatronics Corporation DYNT	-40.5 M	-	14.99 %	$ 929 K	USA
Electromed ELMD	21.2 M	$ 37.69	2.64 %	$ 319 M	USA
Profound Medical Corp. PROF	-288 M	$ 6.66	-1.91 %	$ 201 M	Canada
Butterfly Network BFLY	-879 M	$ 4.57	-11.78 %	$ 1.13 B	USA
Intersect ENT, Inc. XENT	-303 M	-	-	$ 955 M	USA
Second Sight Medical Products EYES	-149 M	-	-0.97 %	$ 54.4 M	USA
GBS GBS	-62.5 M	-	-0.57 %	$ 7.12 M	USA
Globus Medical GMED	1.39 B	$ 80.0	-	$ 10.8 B	USA
Insulet Corporation PODD	287 M	$ 153.22	4.65 %	$ 10.8 B	USA
CONMED Corporation CNMD	589 M	$ 35.16	0.06 %	$ 1.09 B	USA
Sintx Technologies SINT	-292 M	$ 2.03	-9.38 %	$ 5.63 M	USA
Inspire Medical Systems INSP	-146 M	$ 41.19	-2.31 %	$ 1.21 B	USA
Integer Holdings Corporation ITGR	994 M	$ 91.98	-0.82 %	$ 3.19 B	USA
Invacare Corporation IVC	-78.4 M	-	-	$ 24.7 M	USA
Edwards Lifesciences Corporation EW	14.2 B	$ 85.96	-1.7 %	$ 50.3 B	USA